T1	PROC 134 154	tratamento adyuvante
T2	PROC 46 111	Estudio para evaluar la eficacia, la seguridad y la tolerabilidad
T3	CHEM 118 128	pregbalina
T4	DISO 196 224	crisis epilépticas parciales
T5	PROC 248 331	ESTUDIO MULTICÉNTRICO, DE GRUPOS PARALELOS, EN DOBLE CIEGO Y CONTROLADO CON PLACEBO
T6	PROC 826 850	consentimiento informado
#1	AnnotatorNotes T6	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T7	PROC 338 372	EVALUAR LA EFICACIA Y LA SEGURIDAD
#2	AnnotatorNotes T7	C0511730; Identify product efficacy and safety issues; Health Care Activity
T8	CHEM 379 390	PREGABALINA
#3	AnnotatorNotes T8	C0657912; pregabalin; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T9	PROC 396 417	TRATAMIENTO ADYUVANTE
#4	AnnotatorNotes T9	C0677850; Adjuvant therapy; Therapeutic or Preventive Procedure
T10	DISO 466 494	CRISIS EPILÉPTICAS PARCIALES
T11	DISO 518 524	Crisis
#5	AnnotatorNotes T11	C0036572; Seizures; Sign or Symptom
T12	DISO 527 536	epilepsia
#6	AnnotatorNotes T12	C0014544; Epilepsy; Disease or Syndrome
T13	DISO 563 591	Crisis epilépticas parciales
T14	DISO 662 668	crisis
#7	AnnotatorNotes T14	C0036572; Seizures; Sign or Symptom
T15	DISO 758 774	crisis parciales
#8	AnnotatorNotes T15	C0751495; Seizures, Focal; Disease or Syndrome
T16	CHEM 892 916	fármacos antiepilépticos
T17	DISO 962 982	Crisis generalizadas
#9	AnnotatorNotes T17	C0234533; Generalized seizures; Disease or Syndrome
T18	DISO 1058 1076	crisis de ausencia
#10	AnnotatorNotes T18	C4316903; Absence Seizures; Disease or Syndrome
T19	DISO 1078 1093	crisis febriles
#11	AnnotatorNotes T19	C0009952; Febrile Convulsions; Disease or Syndrome
T20	DISO 1097 1116	espasmos infantiles
#12	AnnotatorNotes T20	C3887898; Infantile Spasm; Disease or Syndrome
T21	DISO 1120 1146	Síndrome de Lennox-Gastaut
#13	AnnotatorNotes T21	C0238111; Lennox-Gastaut syndrome; Disease or Syndrome
T22	DISO 1148 1193	epilepsia benigna con puntas centrotemporales
#14	AnnotatorNotes T22	C2363129; Benign Rolandic Epilepsy; Disease or Syndrome | C2875074; Benign childhood epilepsy with centrotemporal EEG spikes; Disease or Syndrome
T23	DISO 1015 1056	crisis clónicas, tónicas, tónico-clónicas
T24	DISO 1196 1214	síndrome de Dravet
#15	AnnotatorNotes T24	C0751122; Infantile Severe Myoclonic Epilepsy; Disease or Syndrome
T25	DISO 1219 1236	Estado epiléptico
#16	AnnotatorNotes T25	C0038220; Status Epilepticus; Disease or Syndrome
T26	PROC 1297 1323	tratamiento antiepiléptico
T27	CHEM 1333 1343	medicación
#17	AnnotatorNotes T27	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T28	DISO 1406 1424	Lesión estructural
T29	ANAT 1440 1464	sistema nervioso central
#18	AnnotatorNotes T29	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T30	ANAT 1466 1469	SNC
#19	AnnotatorNotes T30	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T31	DISO 1473 1486	encefalopatía
#20	AnnotatorNotes T31	C0006111; Brain Diseases; Disease or Syndrome | C0085584; Encephalopathies; Disease or Syndrome
T32	CHEM 1309 1323	antiepiléptico
#21	AnnotatorNotes T32	C0003299; Antiepileptic Agents; Pharmacologic Substance
T33	DISO 1501 1524	Errores del metabolismo
T34	Date 13 17	2013
T35	LIVB 158 163	niños
#22	AnnotatorNotes T35	C0008059; Child; Age Group
T36	Age 168 183	menos de 4 años
T37	LIVB 421 426	NIÑOS
#23	AnnotatorNotes T37	C0008059; Child; Age Group
T38	Age 427 453	DE 1 MES A MENOS DE 4 AÑOS
T39	LIVB 624 631	sujetos
#24	AnnotatorNotes T39	C0681850; Study Subject; Group
T40	Date 683 698	el mes anterior
T41	LIVB 720 727	sujetos
#25	AnnotatorNotes T41	C0681850; Study Subject; Group
T42	Duration 794 802	48 horas
T43	Dose 865 891	una dosis estable de 1 a 3
T45	Date 1240 1255	el año anterior
T46	Duration 1356 1366	los 7 días
T47	PHYS 1513 1524	metabolismo
#26	AnnotatorNotes T47	C0025519; Metabolism; Organism Function
T44	PROC 1383 1402	visita de selección
#27	AnnotatorNotes T44	C1710477; Trial Screening; Research Activity + C1512346; Patient Visit; Health Care Activity
A1	Population_data T35 Age
A2	Population_data T37 Age
A3	Status T14 History_of
A4	Status T15 History_of
A5	Status T25 History_of
#28	AnnotatorNotes T2	C0511730; Identify product efficacy and safety issues; Health Care Activity + C3274448; Tolerability Study; Research Activity
#29	AnnotatorNotes T3	C0657912; pregabalin; Amino Acid, Peptide, or Protein · Pharmacologic Substance
#30	AnnotatorNotes T16	C0003299; Antiepileptic Agents; Pharmacologic Substance
#31	AnnotatorNotes T5	C1096776; Multicenter Study; Research Activity + C2826345; Parallel Study; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#32	AnnotatorNotes T1	C0677850; Adjuvant therapy; Therapeutic or Preventive Procedure
#33	AnnotatorNotes T4	C0751495; Seizures, Focal; Disease or Syndrome
#34	AnnotatorNotes T10	C0751495; Seizures, Focal; Disease or Syndrome
#35	AnnotatorNotes T13	C0751495; Seizures, Focal; Disease or Syndrome
#36	AnnotatorNotes T23	C0494475; Tonic - clonic seizures; Disease or Syndrome + C0234535; Clonic Seizures; Disease or Syndrome + C0270844; Tonic Seizures; Disease or Syndrome 
R1	Used_for Arg1:T3 Arg2:T1	
R2	Experiences Arg1:T35 Arg2:T3	
R3	Has_Age Arg1:T35 Arg2:T36	
R4	Experiences Arg1:T35 Arg2:T4	
R5	Used_for Arg1:T8 Arg2:T9	
R6	Experiences Arg1:T37 Arg2:T8	
R7	Has_Age Arg1:T37 Arg2:T38	
R8	Experiences Arg1:T37 Arg2:T10	
R9	Experiences Arg1:T39 Arg2:T14	
R10	Overlap Arg1:T14 Arg2:T40	
T48	Quantifier_or_Qualifier 651 661	al menos 3
R11	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T48	
T49	Quantifier_or_Qualifier 747 757	al menos 2
R12	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T49	
R13	Experiences Arg1:T41 Arg2:T15	
R14	Has_Duration_or_Interval Arg1:T15 Arg2:T42	
T50	CONC 803 808	basal
#37	AnnotatorNotes T50	C1442488; Baseline; Quantitative Concept
R15	Overlap Arg1:T15 Arg2:T50	
T51	PROC 704 713	selección
#38	AnnotatorNotes T51	C0242802; Patient Selection; Research Activity
R16	Before Arg1:T14 Arg2:T51	
R17	Has_Dose_or_Strength Arg1:T16 Arg2:T43	
T52	PROC 923 932	selección
#39	AnnotatorNotes T52	C0242802; Patient Selection; Research Activity
R18	Overlap Arg1:T16 Arg2:T52	
T53	Quantifier_or_Qualifier 983 992	primarias
#40	AnnotatorNotes T53	C0205225; Primary; Qualitative Concept
R19	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T53	
R20	Overlap Arg1:T25 Arg2:T45	
T54	PROC 1261 1270	selección
#41	AnnotatorNotes T54	C0242802; Patient Selection; Research Activity
R21	Before Arg1:T25 Arg2:T54	
R22	Used_for Arg1:T32 Arg2:T26	
T55	CONC 1284 1290	cambio
#42	AnnotatorNotes T55	C0443172; Changed status; Quantitative Concept
R23	Overlap Arg1:T55 Arg2:T46	
R24	Before Arg1:T55 Arg2:T44	
R25	Location_of Arg1:T29 Arg2:T28	
R26	Location_of Arg1:T30 Arg2:T28	
T56	Quantifier_or_Qualifier 1425 1435	progresiva
#43	AnnotatorNotes T56	C0205329; Progressive; Functional Concept
R27	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T56	
T57	Quantifier_or_Qualifier 1487 1497	progresiva
#44	AnnotatorNotes T57	C0205329; Progressive; Functional Concept
R28	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T57	
T58	Quantifier_or_Qualifier 1525 1536	progresivos
#45	AnnotatorNotes T58	C0205329; Progressive; Functional Concept
R30	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T58	
A6	Experiencer T35 Patient
A7	Experiencer T37 Patient
A8	Experiencer T39 Patient
A9	Experiencer T41 Patient
